FDA Approved: BIVALIRUDIN — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a Civica, Inc.-submitted supplemental application for Bivalirudin, updating its regulatory status for use as an anticoagulant. The approval covers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Heparin-induced Thrombocytopenia
• Ischemic Heart Disease

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

SUPPL AP for BIVALIRUDIN (BIVALIRUDIN)